scholarly journals Dispositivos de asistencia mecánica circulatoria

2018 ◽  
Vol 10 (8) ◽  
pp. 3
Author(s):  
Álvaro Vázquez Lopez-Cepero ◽  
Javier Iborra Escalona ◽  
Vicente Torres-Pedrós

Un dispositivo de asistencia mecánica circulatoria o AMC, es una bomba con capacidad de dar soporte mecánico a un corazón en fallo cardiaco, facilitando el bombeo de la sangre desde las cavidades cardiacas hacia la circulación sistémica. Consideramos asistencia circulatoria a cualquier dispositivo o sistema utilizado para apoyar o sustituir la función cardiaca de forma temporal o, más raramente, permanente. Por norma general nos referimos a las asistencias ventriculares mecánicas y al corazón artificial total.  ABSTRACT A mechanical circulatory assist devices (MCADs) , is a pump capable of giving mechanical support to a heart in heart failure, facilitating the pumping of blood from the cardiac cavities to the systemic circulation. We consider circulatory assistance to any device or system used to support or replace cardiac function temporarily or, more rarely, permanently. As a general rule, we refer to mechanical ventricular assist and total artificial heart.

2018 ◽  
Vol 46 (4) ◽  
pp. 292-300
Author(s):  
Nadia Aissaoui ◽  
Jerome Jouan ◽  
Melissa Gourjault ◽  
Benoit Diebold ◽  
Sofia Ortuno ◽  
...  

Background/Aims: Long-term mechanical assist devices are now commonly used in the treatment of severe heart failure to unload the failing ventricle, maintain sufficient end-organ perfusion and improve functional capacity. Depending on the assisted ventricles, 3 categories of long-term assist devices are available: left ventricular assist device (LVAD), biventricular assist device and total artificial heart. Improvements in technology, especially the advent of smaller, durable continuous flow pumps, have led to the use of LVADs in a much broader population of patients in the last 10 years. Both the number of patients living with LVADs and the life expectancy of these patients are increasing. Regarding this growing number of patients with LVAD, intensivists need to understand the physiology of the devices, their functioning, potential complications and their management. Methods: We performed a narrative review of relevant medical literature regarding the physiology of patients with LVAD and management of common complications relevant to the critical care physicians. Results: The most frequent complications occurring in the LVAD patients after the post-operative period are bleeding, driveline infections, thrombosis, device malfunction, right ventricular failure and arrhythmias. Bleeding is the most frequent adverse event in LVAD due to a combination of anticoagulation and acquired von Willebrand disease secondary to shear stress produced within the pump. Their management includes antiplatelet therapy arrest, reduction of the anticoagulation regimen and specific therapy if feasible. Infection is the second most common cause of death after cardiac failure in LVAD patients. All infections must be aggressively treated to avoid seeding the device. Device thrombosis can develop even when patients are adequately anticoagulated and taking antiplatelet therapy because the LVAD is responsible for a chronic hypercoagulable state. Conclusion: Management of these unique patients in the ICU is best accomplished with a multidisciplinary team that includes specialists in advanced heart failure, LVAD nurse coordinators and intensivists.


Author(s):  
Reza Salabat ◽  
Valluvan Jeevanandam

An increasing number of patients with heart failure need advanced therapy. Heart transplantation remains the definitive long-term treatment, but its use is limited by the low number of donor hearts. This limitation has led to the development of mechanical circulatory support devices that assist cardiac function by direct blood pumping (e.g. ventricular assist devices) and counterpulsation (e.g. the intra-aortic balloon pump). Ventricular assist devices provide long-term treatment for heart failure but are associated with potentially severe complications, such as driveline infection, stroke, and gastrointestinal bleeding. Counterpulsation improves cardiac function by augmenting diastole and reducing afterload, which increases coronary perfusion and decreases cardiac workload. Since the concept was introduced in 1960s, several devices have been used in humans. The intra-aortic balloon pump, a counterpulsation device, is the most commonly used device for short-term support as a bridge to transplant or recovery. A minimally invasive counterpulsation device, such as an intravascular ventricular assist system that allows ambulation, could potentially offer versatile solutions for long-term heart failure therapy or as a bridge to transplant or to recovery. The intravascular ventricular assist system has fewer complications and avoids the need for sternotomy or thoracotomy.


ASAIO Journal ◽  
2006 ◽  
Vol 52 (2) ◽  
pp. 41A ◽  
Author(s):  
Hassan A Khalil ◽  
William Cohn ◽  
Robert J Benkowski ◽  
Ralph W Metcalfe ◽  
Kamuran A Kadipasaoglu ◽  
...  

ASAIO Journal ◽  
2013 ◽  
Vol 59 (2) ◽  
pp. 178-180 ◽  
Author(s):  
Jan Pirk ◽  
Jiri Maly ◽  
Ondrej Szarszoi ◽  
Marian Urban ◽  
Tomas Kotulak ◽  
...  

Author(s):  
Muath Bishawi ◽  
Jun-Neng Roan ◽  
Jordan Richards ◽  
Zachary Brown ◽  
Laura Blue ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document